Neuro-Oncology Reviews
Volume
28 Number 17
20 June 2026
Home > Publications > Neuro-Oncology Reviews > Volume 28, Year 2026 > Number 17, 20 June
Silva Batista AG, Silva Ribeiro Pereira C, Isgarbose Durello EH,
Putini Vieira AC, Fernandes Junior HJ.
Advances
and challenges in glioblastoma immunotherapy: a meta-analysis of
immune checkpoint inhibitors.
Clin
Transl Oncol. 2026 Jun 13. doi:
10.1007/s12094-026-04453-y. PMID:
42287578. ˍ
Wang X, Liu W, Sun J, Wei X, Wang Z, Zang L.
Histone
methylation machinery in gliomas: From enzymatic mechanisms to
inhibitor development.
Cancer
Treat Res Commun. 2026 Jun 13;48:101283. doi:
10.1016/j.ctarc.2026.101283. PMID:
42287776. ˍ
Khattak M, Jadoon I, Umair M, Waqar A, Ullah A, Nisar A, Ahmad J.
Targeting
the tumor microenvironment in glioblastoma: Mechanistic insights,
therapeutic strategies, and advances in immunotherapy.
Life
Sci. 2026 Jun 14;401:124537. doi:
10.1016/j.lfs.2026.124537. PMID:
42289266˰ ˍ
Pollard SM.
Turning
cancer against itself: Programmable genetic medicines for
glioblastoma.
Mol
Ther. 2026 Jun 15;34(7):3748-3750. doi:
10.1016/j.ymthe.2026.06.006. PMID:
42296959˰ ˍ
Sanikommu S, Santos AN, Dawoud B, Shah KH, Vazquez S, Shah AH, Lu
VM.
Chimeric
Antigen Receptor-T Cell Therapy for Pediatric and Young Adult
Primary Central Nervous System Tumors: A Systematic Review of
Early Phase Clinical Trials with a Focus on Diffuse Midline
Glioma.
Target
Oncol. 2026 Jun 15. doi:
10.1007/s11523-026-01225-0. PMID:
42295570. ˍ
Hammond A, Paolini L, Sabet CJ, Garg S, Jadav AA, Arkalgud A,
Ranganathan S, Kohli K, Jain U, Peruzzi P, Messina R, Umana GE,
Ghashghaie G, Shah S, Zhamkochyan A, Mezgebu Bawoke M, Jain B.
Neurosurgical
Care in Italy: A Comprehensive Review and Lessons for High-Income
Nations.
Neurosurg
Pract. 2026 Jun 16;7(3):e000252. doi:
10.1227/neuprac.0000000000000252. PMID:
42305410. ˍ
Zhou L, Luo X, Bao T, Sun H, He C, Yang Y, Xia Y.
Neurobiology
of cancer: Unraveling the roles of the nervous system in tumor
initiation, progression, and therapeutic.
Chin
Med J (Engl). 2026 Jun 16. doi:
10.1097/CM9.0000000000004144. PMID:
42299464. ˍ
Al-Saidi N, Mohammed D, Fatima Z, Bangash AH, Murthy SG, Gelfand
Y, Yassari R, De la Garza Ramos R.
Minimally
invasive approaches to intramedullary spinal cord tumors: a
systematic review of techniques and outcomes.
Eur
Spine J. 2026 Jun 17. doi:
10.1007/s00586-026-10084-2. PMID:
42303793. ˍ
Lehmann U.
Clinical
diagnostic utility of MGMT
promoter
methylation.
Epigenomics.
2026 Jun 17:1-12. doi:
10.1080/17501911.2026.2688974. PMID:
42307140˰ ˍ
Wu B, Duan R, Tu R, Luo M, Ge L, Chen C, Lu M.
Trends
in Ubiquitination Research in Brain Diseases from 1999 to 2024: A
Bibliometric Analysis.
Curr
Med Chem. 2026 Jun 17. doi:
10.2174/0109298673404276260224052525. PMID:
42316494. ˍ
Sayed U, Alieva R, Hanumanthayya M, Singhal D, Panigrahi R, Tailor
NK, Buzrukov T, Norkulov S.
MGMT
promoter methylation across glioma subtypes: biological relevance,
treatment response, and survival outcomes.
Mol
Biol Rep. 2026 Jun 18;53(1):955. doi:
10.1007/s11033-026-12169-z. PMID:
42313202˰ ˍ
Jia B, Zhao L, Tang M, Xie N, Huang Y, Liang X, Yang G, Wu Q, Sun
Z, Kwan HY, Sun H, Xu K.
Neuron-tumor
crosstalk in cancer: molecular mechanisms and translational
advances.
Mol
Cancer. 2026 Jun 19. doi:
10.1186/s12943-026-02715-5. PMID:
42321740. ˍ
Nuss ZJ, DeYoung C, Gross D.
H3K27M-mutant
diffuse midline glioma pharmacotherapy: Clinical evidence and
practice implications of dordaviprone.
J
Oncol Pharm Pract. 2026 Jun 19:10781552261461529. doi:
10.1177/10781552261461529. PMID:
42317168˰ ˍ
Habashy KJ, Arrieta VA, Haupt B, Gómez M, El-Hajj VG, Kim
KS, Dmello C, Chen L, Carpentier A, Canney M, Stupp R, Sonabend
AM.
Development
of skull-implanted ultrasound for blood-brain barrier opening and
drug delivery in neuro-oncology.
Neurooncol
Adv. 2025 Dec 2;8(Suppl 4):iv9-iv19. doi:
10.1093/noajnl/vdaf044. PMID:
42281806. ˍ
Lin C, Llinas M, Lipsman N, Krumholtz S, Mithani K, Hynynen K,
Rutka J.
Focused
ultrasound in pediatric neuro-oncology: Current applications and
future directions.
Neurooncol
Adv. 2025 Dec 2;8(Suppl 4):iv79-iv89. doi:
10.1093/noajnl/vdaf019. PMID:
42281805. ˍ
Ozair A, Moiz B, Anastasiadis P, Gandhi D, Bettegowda C, Mischel
PS, Hong J, Ahluwalia MS, Woodworth GF.
Applications
of transcranial focused ultrasound for primary brain tumors.
Neurooncol
Adv. 2025 Dec 2;8(Suppl 4):iv20-iv39. doi:
10.1093/noajnl/vdaf156. PMID:
42281808. ˍ
Ozair A, Moiz B, Anastasiadis P, Gandhi D, Amatya B, McDermott MW,
Woodworth GF, Ahluwalia MS.
Focused
ultrasound for brain metastases.
Neurooncol
Adv. 2025 Dec 2;8(Suppl 4):iv40-iv59. doi:
10.1093/noajnl/vdaf131. PMID:
42281803. ˍ
Meng Y, Lipsman N.
Focused
ultrasound in neuro-oncology: Realizing the promise of a
noninvasive future.
Neurooncol
Adv. 2026 Mar 20;8(Suppl 4):iv1. doi:
10.1093/noajnl/vdaf231. PMID:
42281804. ˍ
Sherlock T, Thede AT, Sheybani ND.
Focused
ultrasound for enhancing cell-based immunotherapies in
neuro-oncology.
Neurooncol
Adv. 2026 Apr 10;8(Suppl 4):iv60-iv78. doi:
10.1093/noajnl/vdag080. PMID:
42281807. ˍ
Omichi R, Nakajo K, Tanoue Y, Tsujino N, Kohashi K, Ichinose T,
Goto T.
Glioblastoma
With a Primitive Neuronal Component: A Case Report and Review of
the Literature.
Cureus.
2026 May 15;18(5):e108938. doi:
10.7759/cureus.108938. PMID:
42306402. ˍ
Figg JW, Flores CT.
Rewriting
microenvironment immunity in glioblastoma.
Mol
Ther Oncol. 2026 Jun 9;34(2):201245. doi:
10.1016/j.omton.2026.201245. PMID:
42291139. ˍ
Bouffet E, Franz DN, Arrillaga-Romany I, Jalali R.
Approved
Targeted Treatments for Pediatric Brain Tumors.
Am
Soc Clin Oncol Educ Book. 2026 Jun 10;46(3):e517598.
doi:
10.1200/EDBK-26-517598. PMID:
42269123. ˍ
*Chaturvedi A, Poodipedi SC.
Advances
in glioblastoma: Is there light at the end of the tunnel?
Indian
J Med Res. 2026 Jun 10;163(6):697-699. doi:
10.25259/IJMR_1361_2026. PMID:
42295727. ˍ